| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 26 |
| 1 | PREDNISONE | 25 |
| 2 | METHOTREXATE | 24 |
| 3 | PREDNISOLONE | 24 |
| 4 | PREDNISOLONE ORAL | 24 |
| 5 | PREDNISOLONE ORAL SOLUTION | 24 |
| 6 | UPADACITINIB | 20 |
| 7 | ADALIMUMAB | 15 |
| 8 | MYCOPHENOLATE MOFETIL | 13 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLORASONE DIACETATE | 1 | 0.0052 |
| 1 | DELGOCITINIB | 1 | 0.0037 |
| 2 | BARICITINIB | 8 | 0.0026 |
| 3 | SODIUM CITRATE | 1 | 0.0008 |
| 4 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 5 | SENNOSIDES A AND B | 1 | 0.0006 |
| 6 | TOFACITINIB CITRATE | 8 | 0.0006 |
| 7 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 8 | TAPINAROF | 1 | 0.0005 |
| 9 | ABROCITINIB | 2 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 1 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 2 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 3 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 4 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 5 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 9 | 0.0003 |
| 6 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 8 | Janus Kinase Inhibitor [EPC] | 36 | 0.0002 |
| 9 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |